# Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

> **NCT00464672** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 1893 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza virus vaccine
- **BIOLOGICAL:** Comparator influenza vaccine

## Key facts

- **NCT ID:** NCT00464672
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-07
- **Final completion:** 2007-12
- **Target enrollment:** 1893 (ACTUAL)
- **Last updated:** 2015-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464672, "Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00464672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*